Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.37 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22882634 | 1.00 | EPHX2 (0.40) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24921953 | 1.00 | EPHX2 (0.40) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24921954 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24922154 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24922157 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24922148 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24922152 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24921933 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24922149 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 | |
| SCHEMBL24921929 | 0.98 | EPHX1 (0.42) | EPHX2EPHX1L3MBTL4L3MBTL3CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | FLAGSHIP PIONEERING, INC. (US) | 2023-10-19 | — | — | US | disclosed |
| WO-2019199816-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS, INC. (US) | 2019-10-17 | — | — | WO | disclosed |
| WO-2018144649-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | Arvinas, Inc. (US) | 2018-08-09 | — | — | WO | disclosed |
| US-9225336-B2 | Programmable logic device and semiconductor device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-29 | — | — | US | disclosed |
| US-20150116000-A1 | PROGRAMMABLE LOGIC DEVICE AND SEMICONDUCTOR DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| US-8952723-B2 | Programmable logic device and semiconductor device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-02-10 | — | — | US | disclosed |
| US-20140225644-A1 | PROGRAMMABLE LOGIC DEVICE AND SEMICONDUCTOR DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| US-5986042-A | Cross-linked polymer | MITSUI CHEMICALS, INC. (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0856539-A1 | Cross-linked polymer | Mitsui Chemicals, Inc. (JP) | 1998-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | EFTUD2, DDX21, SNRPE | EPHX2 1836/4885EPHX1 4246/4885L3MBTL4 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.